Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nisreen Okba and Bart Haagmans.
Nisreen Okba
Connection Strength
6.627
Bart Haagmans
  1. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV. Emerg Microbes Infect. 2020 Dec; 9(1):1080-1091.
    View in: PubMed
    Score: 0.916
  2. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients. Emerg Infect Dis. 2020 Jul; 26(7):1478-1488.
    View in: PubMed
    Score: 0.888
  3. Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies. Emerg Infect Dis. 2020 May; 26(5):1024-1027.
    View in: PubMed
    Score: 0.882
  4. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections. Emerg Infect Dis. 2019 10; 25(10):1868-1877.
    View in: PubMed
    Score: 0.847
  5. Middle East respiratory syndrome coronavirus vaccines: current status and novel approaches. Curr Opin Virol. 2017 04; 23:49-58.
    View in: PubMed
    Score: 0.712
  6. Susceptibility of rabbits to SARS-CoV-2. Emerg Microbes Infect. 2021 Dec; 10(1):1-7.
    View in: PubMed
    Score: 0.245
  7. SARS-CoV-2 Neutralizing Human Antibodies Protect Against Lower Respiratory Tract Disease in a Hamster Model. J Infect Dis. 2021 06 15; 223(12):2020-2028.
    View in: PubMed
    Score: 0.238
  8. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science. 2020 05 29; 368(6494):1012-1015.
    View in: PubMed
    Score: 0.219
  9. Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors. J Virol. 2019 08 15; 93(16).
    View in: PubMed
    Score: 0.209
  10. Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection. Sci Adv. 2018 08; 4(8):eaas9667.
    View in: PubMed
    Score: 0.195
  11. MERS-coronavirus: From discovery to intervention. One Health. 2017 Jun; 3:11-16.
    View in: PubMed
    Score: 0.174
  12. An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels. Science. 2016 Jan 01; 351(6268):77-81.
    View in: PubMed
    Score: 0.162
  13. Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination. Proc Natl Acad Sci U S A. 2021 07 13; 118(28).
    View in: PubMed
    Score: 0.060
  14. Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection. Nat Commun. 2021 05 27; 12(1):3189.
    View in: PubMed
    Score: 0.059
  15. A single subcutaneous or intranasal immunization with adenovirus-based SARS-CoV-2 vaccine induces robust humoral and cellular immune responses in mice. Eur J Immunol. 2021 07; 51(7):1774-1784.
    View in: PubMed
    Score: 0.059
  16. A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies. Nat Commun. 2021 03 17; 12(1):1715.
    View in: PubMed
    Score: 0.058
  17. Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection. Cell. 2021 03 04; 184(5):1188-1200.e19.
    View in: PubMed
    Score: 0.058
  18. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021 01 11; 12(1):267.
    View in: PubMed
    Score: 0.058
  19. SARS-CoV-2 is transmitted via contact and via the air between ferrets. Nat Commun. 2020 07 08; 11(1):3496.
    View in: PubMed
    Score: 0.056
  20. An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment. Nat Commun. 2020 07 06; 11(1):3436.
    View in: PubMed
    Score: 0.056
  21. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol. 2020 06 26; 5(48).
    View in: PubMed
    Score: 0.056
  22. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020 08 07; 369(6504):643-650.
    View in: PubMed
    Score: 0.055
  23. Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 2020 05 14; 11(1):2511.
    View in: PubMed
    Score: 0.055
  24. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun. 2020 05 04; 11(1):2251.
    View in: PubMed
    Score: 0.055
  25. MERS-CoV in Camels but Not Camel Handlers, Sudan, 2015 and 2017. Emerg Infect Dis. 2019 12; 25(12):2333-2335.
    View in: PubMed
    Score: 0.053
  26. Lack of Middle East Respiratory Syndrome Coronavirus Transmission in Rabbits. Viruses. 2019 04 24; 11(4).
    View in: PubMed
    Score: 0.051
  27. Blocking transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) in llamas by vaccination with a recombinant spike protein. Emerg Microbes Infect. 2019; 8(1):1593-1603.
    View in: PubMed
    Score: 0.050
  28. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein. Emerg Microbes Infect. 2019; 8(1):516-530.
    View in: PubMed
    Score: 0.050
  29. Middle East respiratory syndrome coronavirus specific antibodies in naturally exposed Israeli llamas, alpacas and camels. One Health. 2018 Jun; 5:65-68.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.